| 23-May-2007 | S | Stock Split
inter alia, has recommended split of Equity Shares from face value of Rs 10/- each to Rs 2/- each, subject to approval of members. The Board decided to take the shareholders approval through postal Ballot and approved the notice alongwith explanatory statement to be sent to shareholders.
Divi'S Laboratories Limited has informed the Exchange that the Board of Directors
of the Company, at their meeting held on May 23, 2007, have recommended split of Equity Shares from face value of Rs 10/- each to RS 2/- each,
subject to approval of members. The Board decided to take the shareholders approval through postal Ballot and approved the notice along with explanatory statement to be sent to shareholders.
(As Per NSE Bulletin Dated on 24/05/2007)
Divis Laboratories Ltd has informed BSE that the Register of Members & Share Transfer Books of the Company will remain closed from August 10, 2007 to August 13, 2007 (both days inclusive) for the purpose of sub-division of Equity Shares of the Company to Rs 2/- per share from the existing Face Value of Rs 10/- per share & Annual General Meeting (AGM) of the Company to be held on September 03, 2007.
(As Per BSE Announcement Website Dated on 11/07/2007)
SUB. :- Sub Division of equity shares of Divis Laboratories Limited (Scrip Code 532488)
Trading members of the Exchange are hereby informed that, Divis Laboratories Limited has fixed the Book Closure for the purpose of sub division of equity shares of the company.
COMPANY NAME
CODE
Divis Laboratories Limited
532488 & 632488
BOOK CLOSURE DATE 10/08/2007 To 13/08/2007
SUB-DIVIDED PAID-UP VALUE Rs.2/-
SUB-DIVIDED PAID-UP VALUE W.E.F.
03/08/2007 DR-089/2007-2008
PURPOSE
Sub Division of existing equity shares from every ONE equity share of Rs.10/- each into FIVE equity shares of Rs.2/- each.
The auction in the equity shares of Divis Laboratories Limited in Dematerialised Securities - Rolling Settlement Segment on 03/08/2007, 06/08/2007 and 07/08/2007 will be conducted as per face value of Rs.10/- each. Trading members are, therefore, requested to take abundant precautions while mentioning the rates for offering the equity shares of the said company in auction on the said dates.
The scrip will be No Delivery from 03/08/2007 (DR-089/2007-2008) to 09/08/2007 (DR-093/2007-2008).
Note :-
i. Trading members are hereby informed that the transactions in the equity shares (physical) of the aforesaid company in the Exit-Route Scheme will be for Rs.2/- paid up w.e.f. 03/08/2007.
ii. ISIN No. INE361B01016 of Rs.10/- paid up will not be valid for transactions done on the Exchange on or after 03/08/2007, except for the auction transactions, which will be conducted on 03/08/2007, 06/08/2007 and 07/08/2007 respectively.
iii. The new ISIN Number for Rs.2/- paid up will be informed to the market by a separate notice.
(As per BSE Notice dated on 13/07/2007)
Trading Members of the Exchange were informed vide Notice No. 20070713-20 dated July 13, 2007, that Divi's Laboratories Limited (Scrip Code: 532488 & 632488) has sub-divided their equity shares from Rs. 10/- paid up per share to Rs. 2/- paid up per share.
In this connection, the company has informed the Exchange that the new ISIN. No. INE361B01024 has been allotted for the sub-divided equity shares consequent to sub-division.
(As per BSE Notice dated on 13/08/2007) | 10-Aug-2007 | |
| 20-May-2023 | D | Recommended a Dividend of ? 30/- (i.e. 1,500%) per equity share of face value ? 2/- each
for the financial year 2022-23, subject to approval of the members at the ensuing 33rd Annual
General Meeting (AGM). The dividend shall be credited / warrants thereof dispatched
within specified timelines from the conclusion of the AGM. The AGM date and record date
for the purpose of the payment of dividend will be announced in due course.
| 11-Aug-2023 | |
| 23-May-2022 | D | Divis Laboratories Ltd has informed BSE that the Board of Directors of the Company at its meeting held on May 23, 2022, inter alia, has recommended a Dividend of Rs. 30/- (i.e. 1500%) per equity share of face value Rs. 2/- each for the financial year 2021-22, subject to approval of the members at the ensuing 32nd Annual General Meeting (AGM). The dividend shall be credited/ warrants thereof dispatched within 30 (thirty) days from the conclusion of the AGM. | 11-Aug-2022 | |
| 29-May-2021 | D | As per enclosed | 17-Aug-2021 | |
| 12-Feb-2020 | D | Divis Laboratories Ltd has informed BSE that the Board of Directors of the Company at its meeting held on February 12, 2020, inter alia, has declared an Interim Dividend of Rs. 16/- (Rupees Sixteen Only) per equity share of Rs. 2/- each for the financial year 2019-20.
The payment of the interim dividend would be made to the eligible shareholders on or before March 05, 2020. | 25-Feb-2020 | |
| 27-May-2019 | D | Divis Laboratories Ltd has informed BSE that the Board of Directors of the Company at its meeting held on May 25, 2019, inter alia, has recommended dividend @ 800% i.e Rs. 16/- per equity share of face value Rs. 2/- each for the financial year 2018-19, subject to approval of the members at the ensuing Annual General Meeting (AGM). The dividend on Equity Shares, shall be credited/ dispatched within 30 (thirty) days from the conclusion of the AGM. | 14-Aug-2019 | |
| 28-May-2018 | D | Divis Laboratories Ltd has informed BSE that the Board of Directors of the Company at its meeting held on May 26, 2018, inter alia, has recommended dividend @ 500% i.e. Rs. 10/- per equity share of face value Rs. 2/- each for the financial year 2017-18, subject to approval of the member in the ensuing Annual General Meeting (AGM). The dividend on Equity Shares, shall be credited/ dispatched within 30 (thirty) days from the conclusion of the AGM, the date of which will be intimated in due course. | 31-Aug-2018 | |
| 26-May-2017 | D | Divis Laboratories Ltd has informed BSE that the Board of Directors of the Company at its meeting held on May 26, 2017, inter alia, has recommended dividend @ 500% i.e Rs. 10/- per equity share of face value Rs. 2/- each for the year ended March 31, 2017, subject to approval of the member in ensuing Annual General Meeting (AGM). The dividend on Equity Shares, shall be paid within 30 (thirty) days from the conclusion of the AGM, the date of which will be intimated in due course. | 15-Sep-2017 | |
| 10-Mar-2016 | D | Divis Laboratories Ltd has informed BSE that the Board of Directors of the Company at its meeting held on March 10, 2016, has declared an interim dividend @ Rs. 10/-per equity share of face value of Rs. 2/- each for the financial year 2015-16.
The interim dividend will be credited / dispatched on or before March 29, 2016.
Divis Laboratories Ltd has informed BSE that the Board of Directors of the Company at its meeting held on May 28, 2016, inter alia, has recommended the interim dividend declared as final dividend for the year ended March 31, 2016.
(As per BSE Announcement dated on 28.05.2016) | 17-Mar-2016 | |
| 23-May-2015 | D | Divis Laboratories Ltd has informed BSE that the Board of Directors of the Company at its meeting held on May 23, 2015, inter alia, has recommended a dividend of 1000% i.e. Rs. 20/- per equity share of Rs. 2/- face value for the year ended March 31, 2015. The dividend on Equity Shares, shall be paid within 30 (thirty) days from the conclusion of the ensuing Annual General Meeting, the date of which will be intimated in due course. | 06-Aug-2015 | |
| 26-May-2014 | D | Divis Laboratories Ltd has informed BSE that the Board of Directors of the Company at its meeting held on May 24, 2014, inter alia, has recommended a dividend of 1000% i.e. Rs. 20/- per equity shares of Rs. 2/- face value for the year ended March 31, 2014. | 31-Jul-2014 | |
| 20-May-2013 | D | Divis Laboratories Ltd has informed BSE that Prof. C. Ayyanna, Independent Director of the Company has resigned from the Board due to personal reasons and other pre-occupations.
The Beard has accepted his resignation and appreciated his contribution to the Company.
Divis Laboratories Ltd has informed BSE that the Board of Directors of the Company at its meeting held on May 20, 2013, inter alia, has recommended a dividend of 750% i.e. Rs. 15/- per equity share of Rs. 2/- face value for the year ended March 31, 2013. | 25-Jul-2013 | |
| 12-May-2012 | D | Divis Laboratories Ltd has informed BSE that the Board of Directors of the Company at its meeting held on May 12, 2012, inter alia, has recommended a dividend of 650% i.e. Rs. 13/- per equity share of Rs. 2/- face value for the year ended March 31, 2012. | 26-Jul-2012 | |
| 20-May-2011 | D | Divis Laboratories Ltd has informed BSE that the Board of Directors of the Company at its meeting held on May 20, 2011, inter alia, has recommended a dividend of 500% i.e. Rs. 10/- per equity share of Rs. 2/- face value for the year ended March 31, 2011. | 16-Jun-2011 | |
| 24-May-2010 | D | Divis Laboratories Ltd has informed BSE that the Board of Directors of the Company at its meeting held on May 22, 2010, inter alia, has recommended a dividend of 300% i.e. Rs. 6/- per equity share of Rs. 2/- face value for the year ended March 31, 2010. | 02-Jul-2010 | |
| 06-Jun-2009 | D | Divis Laboratories Ltd has informed BSE that the Board of Directors of the Company at its meeting held on June 06, 2009, inter alia, has recommended a dividend of Rs 6/- per equity share of Rs 2 each i.e. 300% for the year ended March 31, 2009. | 15-Jun-2009 | |
| 09-Jun-2008 | D | Divis Laboratories Ltd has informed BSE that the Board of Directors of the Company at its meeting held on June 07, 2008, inter alia, has recommended a dividend of 200% on equity shares for the year ended March 31, 2008. | 26-Jun-2008 | |
| 19-Mar-2007 | D | Divis Laboratories Ltd has informed BSE that the Board of Directors of the Company at its meeting held on March 17, 2007, has declared an interim dividend @ 100% (Rs 10/- per share) on Equity Capital of the Company for the financial year 2006-07 to all the Equity Shareholders. | 23-Mar-2007 | |
| 29-Aug-2005 | D | 80% Final Dividend | 11-Aug-2005 | |
| 14-Sep-2015 | B | 1:1 Bonus Issue of Equity Shares
SUB. :- Bonus issue of Divi's Laboratories Ltd. (Scrip Code: 532488)
Trading Members of the Exchange are hereby informed that, Divi's Laboratories Ltd. has fixed the Record Date for the purpose of Bonus Issue. The transactions in the equity shares of the company would be on an ex-bonus basis with effect from the under mentioned date.
DEMATERIALISED SECURITIES - ROLLING SETTLEMENT SEGMENT
COMPANY NAME & CODE
Divi's Laboratories Ltd.
(432488;532488; 632488)
RECORD DATE
26.09.2015
PURPOSE
Issue of 1 (ONE) Bonus equity share for every 1 (ONE) existing equity share held.
Ex-Bonus basis from Date & Sett. No.
23/09/2015 DR-123/2015-2016
Trading Members of the Exchange are requested to take note of it.
(As Per BSE Notice Dated on 15.09.2015) | 26-Sep-2015 | 1:1 |
| 24-Jul-2009 | B | SUB. :- Bonus issue of Divi's Laboratories Ltd. (Scrip Code 532488)
Trading Members of the Exchange are hereby informed that, Divi's Laboratories Ltd. has fixed the Record Date for the purpose of Bonus Issue. The transactions in the equity shares of the company should be on an ex-bonus basis with effect from the under mentioned date.
DEMATERIALISED SECURITIES - ROLLING SETTLEMENT SEGMENT
COMPANY NAME CODE
Divi's Laboratories Ltd.
(532488)
RECORD DATE
01/08/2009
PURPOSE
1 (ONE) fully paid up Bonus equity share for every 1 (ONE) existing equity share held.
TRANSACTIONS IN EQUITY SHARES ON
Cum-Bonus basis up to Date & Sett. No.
29/07/2009 DR-082/2009- 2010
Ex-Bonus basis from Date & Sett. No
30/07/2009 DR-083/2009-2010
Trading Members of the Exchange are requested to take note of it. | 01-Aug-2009 | 1:1 |
| 04-Mar-2024 | BC | Submission of Postal Ballot Notice dated February 10, 2024. | 04-Apr-2024 | |
| 04-Mar-2024 | BC | Submission of Postal Ballot Notice dated February 10 2024.
POM 06/04/2024
(As Per BSE Bulletin Dated on 04.02.2024)
Newspaper advertisement relating to Postal Ballot Notice
(As per BSE An | 04-Apr-2024 | |
| 10-Feb-2024 | BC | As per enclosed attachment. | 31-Mar-2024 | |
| 10-Feb-2024 | BC | As per enclosed attachment. | 28-Mar-2024 | |
| 30-Jan-2024 | BC | DIVIs LABORATORIES LTD.has informed BSE that the meeting of the Board of Directors of the Company is scheduled on 10/02/2024 inter alia to consider and approve the standalone and consolidated unaudit | 10-Feb-2024 | |